eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | myeloid leukemia |
| Comorbidity | C0023418|leukemia |
| Sentences | 41 |
| PubMedID- 24765265 | Acute promyelocytic leukemia (apl), m3 subtype of acute myeloid leukemia (aml) is characterized in the majority of cases by proliferation of neoplastic hypergranlar promyelocytes and blast.1 the biological and clinical heterogenicity of apl is based on the clinical presentation of the disease and various characteristics of leukemic cells at diagnosis. |
| PubMedID- 22443687 | The study proves the concept that curcumin is therapeutically effective against human acute monocytic leukemia, one key type of acute myeloid leukemia. |
| PubMedID- 24522270 | Mll-rearranged leukemia is a subset of acute myeloid leukemia (aml) with poor prognosis. |
| PubMedID- 23134869 | [secondary acute leukemia after remission of patients with acute promyelocytic leukemia: 3 cases and literature review]. |
| PubMedID- 21393960 | Exfoliative dermatitis with leukemia cutis in a patient with chronic myeloid leukemia: a rare association. |
| PubMedID- 22787381 | Of note, acute promyelocytic leukemia (apl), a form of acute myeloid leukemia (aml; m3), shows prominently favorable clinical outcomes compared to other types of aml. |
| PubMedID- 19903674 | Background: acute promyelocytic leukemia is a subtype of acute myeloid leukemia characterized by the t(15;17). |
| PubMedID- 25797266 | M5 leukemia is one subtype of acute myeloid leukemia (aml). |
| PubMedID- 20922786 | Tyrosine kinase inhibitor (tki) treatment targeting breakpoint cluster region-abelson murine leukemia virus, the cause of chronic myeloid leukemia (cml), has revolutionized therapy for patients with this disease. |
| PubMedID- 20362549 | These cells newly evolved from pluripotent leukemia stem cells of chronic myeloid leukemia in the chronic phase. |
| PubMedID- 21172090 | Continued conduct of studies that include all types of breast cancers is akin to conducting a trial for leukemia where patients with acute myeloid leukemia, acute lymphocytic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, and so on, are all eligible for participation. |
| PubMedID- 24152491 | Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia. |
| PubMedID- 21548944 | Seventy-seven newly diagnosed and untreated cases of leukemia, including 24 with acute myeloid leukemia (aml); 14 with chronic phase chronic myeloid leukemia (cml); 18 with t-cell acute lymphocytic leukemia/lymphoma (t-all); 12 with b-cell all (b-all); and nine with b-cell chronic lymphocytic leukemia (b-cll). |
| PubMedID- 22543830 | Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor. |
| PubMedID- 22541123 | [an unusual child case of myeloid/natural killer cell precursor acute leukemia treated successfully with acute myeloid leukemia-oriented chemotherapy]. |
| PubMedID- 21302443 | Objective: to study the proliferative inhibition effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with ph(+), chronic myelogenous leukemia cell line k562 expressing p210 protein and acute lymphoblastic leukemia cell line sup-b15 expressing p190 protein. |
| PubMedID- 22937049 | Acute promyelocytic leukemia (apl), a subtype of acute myelogenous leukemia, is a cancer of the blood and bone marrow. |
| PubMedID- 26466808 | leukemia stem cells (lscs) of chronic myeloid leukemia (cml) are refractory to tyrosine kinase inhibitor treatment, persist in the residual disease, and are important source for disease recurrence. |
| PubMedID- 20377918 | Introduction: the development of philadelphia chromosome (ph) negative acute leukemia/myelodysplastic syndrome (mds) in patients with ph-positive chronic myeloid leukemia (cml) is very rare. |
| PubMedID- 23484688 | [clinical significance of common leukemia gene mutations in patients with acute promyelocytic leukemia]. |
| PubMedID- 20184209 | leukemia cutis in a patient with acute myelogenous leukemia: a case report and review of the literature. |
| PubMedID- 24744618 | Material and methods: the study included 50 leukemia patients (31 with acute myeloid leukemia, 5 with acutelymphoblastic leukemia, 9 with chronic myeloid leukemia, and 5 with chronic lymphocytic leukemia) that underwentpcr-sscp, followed by direct dna sequencing. |
| PubMedID- 21343549 | Tet2 mutations improve the new european leukemianet risk classification of acute myeloid leukemia: a cancer and leukemia group b study. |
| PubMedID- 25745544 | Bone involvement can also rarely occur in acute lymphoblastic leukemia and blast crisis of chronic myeloid leukemia.12 other tumor presenting with predominant bone destruction at this age is ewing’s sarcoma. |
| PubMedID- 22745659 | Chromosomal translocations that result in mll (mixed-lineage leukemia)-fusion oncogenes are associated with acute myeloid leukemia (aml), acute lymphoblastic leukemia (all), myelodysplastic syndrome, and secondary therapy-related acute leukemia [1]. |
| PubMedID- 22035377 | Ras mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia. |
| PubMedID- 23738923 | Objective: molecular monitoring using quantitative polymerase chain reaction (qpcr) of bcr-abl mrna transcripts using the international scale (is) is recommended by the national comprehensive cancer network and the european leukemianet for patients with chronic myelogenous leukemia in chronic phase (cml-cp). |
| PubMedID- 20178013 | Among the 114 acute leukemias, 14/63 (22.22%) of the acute myeloid leukemia samples were positive for xage-1b genes. |
| PubMedID- 24876163 | Acute promyelocytic leukemia, an aggressive subtype of acute myeloid leukemia, is characterized by the t(15;17) translocation. |
| PubMedID- 20819538 | Background: recent studies have shown that interleukin-3 receptor alpha (cd123) is highly expressed on leukemia stem cells of patients with acute myeloid leukemia, and is correlated with tumor load and poor prognosis. |
| PubMedID- 24891015 | However, patients with bcr-abl1(+) acute lymphoblastic leukemia and subsets of patients with chronic myeloid leukemia are at high risk of relapse despite kinase inhibition therapy, necessitating novel treatment strategies. |
| PubMedID- 24637061 | Previous studies indicated that in acute promyelocytic leukemia (apl), a subtype of acute myelogenous leukemia (aml) bearing the leukemia promoting pml/raralpha fusion protein, let-7c expression seems to be controlled by the host gene promoter, in which canonical retinoic acid responsive elements (rares) are bound by l/raralpha in an all transretinoic acid (atra)-sensitive manner. |
| PubMedID- 25196855 | The cumulative incidence of emr was 4.0% at 3 years, and the incidence was higher in acute lymphoblastic leukemia patients compared with acute myeloid leukemia patients (5.6% versus 2.4%). |
| PubMedID- 20105281 | Results: here we show that this assumption is not correct, because the channel is up-regulated in myelodysplastic syndromes, chronic myeloid leukemia and almost half of the tested acute myeloid leukemias in a subtype-dependent fashion. |
| PubMedID- 24602197 | leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings. |
| PubMedID- 24676459 | Cd56 is recognized as an unfavorable prognostic marker in cases of acute myeloid leukemia with t(8;21), acute promyelocytic leukemia, and anaplastic large cell lymphoma. |
| PubMedID- 22184394 | Hairy cell leukemia variant in a patient with chronic myeloid leukemia receiving nilotinib: sequential or coincidental. |
| PubMedID- 25088254 | The acute promyelocytic leukemia (apl) subtype of acute myeloid leukemia (aml) is characterized by chromosomal translocations that result in fusion proteins, including the promyelocytic leukemia-retinoic acid receptor, alpha fusion protein (pml-raralpha). |
| PubMedID- 24769565 | For example, acute promyelocytic leukemia (apl), a subtype of acute myeloid leukemia (aml), has been successfully treated with therapy which utilizes all-trans-retinoic acid (atra). |
| PubMedID- 25369030 | Acute promyelocytic leukemia (apl), a subtype of acute myeloid leukemia characterized by the formation of a pml-raralpha fusion protein, leads to the accumulation of abnormal promyelocytes. |
| PubMedID- 25622682 | Acute leukemia (al), mainly consisting of acute myeloid leukemia (aml) and acute lymphoblastic leukemia (all), is currently the major cause of death in hematological malignancies, affecting patients of all ages. |
Page: 1